Breast Cancer Research and Treatment

, Volume 149, Issue 1, pp 263–268 | Cite as

No effect of scalp cooling on survival among women with breast cancer

  • J. Lemieux
  • L. Provencher
  • L. Perron
  • J. Brisson
  • C. Amireault
  • C. Blanchette
  • E. Maunsell
Epidemiology

Abstract

Scalp cooling can prevent chemotherapy-induced alopecia in some cancer patients. It is not used in all countries. No data are available regarding its impact, if any, on survival. The aim of this study was to compare overall survival according to whether or not scalp cooling was used during neoadjuvant or adjuvant chemotherapy for non-metastatic breast cancer. We conducted a retrospective cohort study of 1,370 women with non-metastatic invasive breast carcinoma who received chemotherapy in the neoadjuvant or adjuvant setting. A total of 553 women who used scalp cooling came from a tertiary breast cancer clinic in Quebec City (diagnosed between 1998 and 2002) and 817 were treated in other hospitals in the province of Quebec (between 1998 and 2003) where scalp cooling was not routinely available. Overall survival of women who used scalp cooling and those who did not was compared using Cox proportional hazards models. Median follow-up for the scalp-cooled and the non-scalp-cooled groups was 6.3 years and 8.0 years, respectively. Overall mortality was no different (adjusted hazard ratio 0.89, 95 % confidence interval: 0.68–1.17, p = 0.40) among scalp-cooled women, compared to those not getting scalp cooling. Among women getting neoadjuvant or adjuvant chemotherapy for non-metastatic breast cancer, scalp cooling used to prevent chemotherapy-induced alopecia had no negative effect on survival. To our knowledge, this is the first study to compare survival of women who used scalp cooling to that of women who did not.

Keywords

Breast cancer Scalp cooling Survival Alopecia 

References

  1. 1.
    Mulders M, Vingerhoets A, Breed W (2008) The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians. Eur J Oncol Nurs 12(2):97–102PubMedCrossRefGoogle Scholar
  2. 2.
    Lemieux J, Maunsell E, Provencher L (2008) Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psycho Oncol 17(4):317–328CrossRefGoogle Scholar
  3. 3.
    Sedlacek SM (2006) Persistent significant alopecia (PSA) from adjuvant docetaxel after doxorubicin/cyclophosphamide (AC) chemotherapy in women with breast cancer. Breast Cancer Res Treat 100:s116–s116 Abstract No 2105Google Scholar
  4. 4.
    Breed WP, Van den Hurk CJG, Peerbooms M (2011) Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations. Exp Rev Dermatol 6(1):109–125CrossRefGoogle Scholar
  5. 5.
    Grevelman EG, Breed WP (2005) Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol 16(3):352–358PubMedCrossRefGoogle Scholar
  6. 6.
    van den Hurk CJ, Peerbooms M, van de Poll-Franse LV, Nortier JW, Coebergh JW, Breed WP (2012) Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry. Acta Oncol 51(4):497–504. doi:10.3109/0284186X.2012.658966 PubMedCrossRefGoogle Scholar
  7. 7.
    Edelstyn GA, MacDonald M, MacRae KD (1977) Doxorubicin-induced hair loss and possible modification by scalp cooling. Lancet 2(8031):253–254PubMedCrossRefGoogle Scholar
  8. 8.
    Hillen HFP, Breed WPM, Botman CJ (1990) Scalp cooling by cold air for the prevention of chemotherapy-induced alopecia. Neth J Med 37(5–6):231–235PubMedGoogle Scholar
  9. 9.
    van de Sande MA, van den Hurk CJ, Breed WP, Nortier JW (2010) Allow scalp cooling during adjuvant chemotherapy in patients with breast cancer; scalp metastases rarely occur. Ned Tijdschr Geneeskd 154:A2134PubMedGoogle Scholar
  10. 10.
    Lemieux J, Amireault C, Provencher L, Maunsell E (2009) Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling. Breast Cancer Res Treat 118(3):547–552PubMedCrossRefGoogle Scholar
  11. 11.
    Perron L, Major D, Hébert-Croteau N, Brisson J (2011) Évolution de la détection précoce, l’investigation, le traitement et la survie chez les femmes avec un cancer du sein diagnostiqué entre 1993 et 2003 au Québec, 2011th edn. Institut national de santé publique du Québec, QuébecGoogle Scholar
  12. 12.
    Cox D (1972) Regression models and life tables. J Stat Soc 34:187–220Google Scholar
  13. 13.
    Gooiker GA, van Gijn W, Post PN, van de Velde CJ, Tollenaar RA, Wouters MW (2010) A systematic review and meta-analysis of the volume-outcome relationship in the surgical treatment of breast cancer. Are breast cancer patients better of with a high volume provider? Eur J Surg Oncol 36:S27–S35PubMedCrossRefGoogle Scholar
  14. 14.
    van den Hurk CJ, Mols F, Vingerhoets AJ, Breed WP (2010) Impact of alopecia and scalp cooling on the well-being of breast cancer patients. Psycho oncol 19(7):701–709. doi:10.1002/pon.1615 CrossRefGoogle Scholar
  15. 15.
    El-Saka RO, El-Husseiny, G., Rostom, Y., Salama, A., (2009) Scalp cooler efficacy to reduce anthracycline-induced alopecia and its QOL impact in breast cancer. In: ASCO, 2009Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • J. Lemieux
    • 1
    • 2
    • 3
  • L. Provencher
    • 1
    • 2
    • 4
  • L. Perron
    • 5
    • 6
  • J. Brisson
    • 1
    • 2
    • 5
    • 6
  • C. Amireault
    • 7
  • C. Blanchette
    • 1
    • 2
  • E. Maunsell
    • 1
    • 2
    • 5
  1. 1.Centre de rechercheCentre hospitalier universitaire (CHU) de Québec, Hôpital du Saint-SacrementQuébecCanada
  2. 2.Centre des Maladies du Sein Deschênes-FabiaCentre hospitalier universitaire (CHU) de Québec-Hôpital du St-SacrementQuebecCanada
  3. 3.Département de médecine, Faculté de MédecineUniversité Laval, Pavillon Ferdinand-VandryQuebecCanada
  4. 4.Département de chirurgie, Faculté de MédecineUniversité Laval, Pavillon Ferdinand-VandryQuebecCanada
  5. 5.Département de médecine sociale et préventive, Faculté de MédecineUniversité Laval, Pavillon Ferdinand-VandryQuebecCanada
  6. 6.Institut Nationale de Santé PubliqueQuebecCanada
  7. 7.Faculté de MédecineUniversité Laval, Pavillon Ferdinand-VandryQuebecCanada

Personalised recommendations